Benitec Biopharma Inc.
General ticker "BNTC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $600.5M (TTM average)
Benitec Biopharma Inc. follows the US Stock Market performance with the rate: 2.5%.
Estimated limits based on current volatility of 2.8%: low 8.22$, high 8.69$
Factors to consider:
- Total employees count: 19 (+18.8%) as of 2025
- Top business risk factors: Incur losses, Operational and conduct risks, Raising new funds, Clinical trial failure, Manufacturing issues
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-06-30 to 2028-06-29
- 2026-06-30 to 2027-06-30 estimated range: [7.49$, 16.55$]
- 2027-06-30 to 2028-06-29 estimated range: [6.62$, 14.96$]
Short-term BNTC quotes
Long-term BNTC plot with estimates
Financial data
| YTD | 2024-06-30 | 2025-06-30 | 2026-06-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $22.49MM | $41.77MM | $51.19MM |
| Operating Income | $-22.49MM | $-41.77MM | $-51.19MM |
| Non-Operating Income | $0.74MM | $3.85MM | $5.65MM |
| R&D Expense | $15.61MM | $18.33MM | $23.39MM |
| Income(Loss) | $-21.75MM | $-37.92MM | $-45.55MM |
| Net Income(Loss)* | $-21.75MM | $-37.92MM | $-45.55MM |
| Stockholders Equity | $47.25MM | $97.30MM | $177.01MM |
| Assets | $52.21MM | $99.59MM | $182.62MM |
| Operating Cash Flow | $-19.40MM | $-23.59MM | $-16.52MM |
| Capital expenditure | $0.18MM | $0.02MM | $0.10MM |
| Investing Cash Flow | $-0.18MM | $-0.02MM | $-0.10MM |
| Financing Cash Flow | $68.03MM | $70.48MM | $98.98MM |
| Earnings Per Share** | $-2.12 | $-1.05 | $-0.98 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.